StonvexLoading…
StonvexStonvexStonvexCore line items from FGNX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $232.00K | $2.41M | $1.34M | $15.71M |
Operating Income | $-40.22M | $-64.00M | $373.00K | $-3.56M |
Net Income | $-38.64M | $-66.74M | $-7.67M | $5.47M |
EPS (Diluted) | $-5.88 | $-25.69 | $-1.88 | $-4.07 |
Total Assets | $95.68M | $163.84M | $244.74M | $92.86M |
Total Liabilities | $4.93M | $20.35M | $13.72M | $23.52M |
Cash & Equivalents | $14.14M | $13.39M | $7.50M | $11.08M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $-4.13M |
Shares Outstanding | 6.53M | 7.08M | 39.83M | 1.28M |